Skip to main content
search

With summer and its hot sunny days coming soon, Comprehensive Cancer Centers gets everyone informed about the risks and precautions necessary for melanoma.

With the heat and days of summer sun fast approaching, Comprehensive Cancer Centers and its physicians want everyone to get better informed about melanoma. While risks persist for this type of cancer all year long, melanoma represents one of the most serious and complex challenges in the field of oncology, and summer coming provides a good time to learn more about the disease and how to reduce risks.

Melanoma Skin Cancer: Risks, Symptoms, and Prevention
Melanoma originates in the cells that provide the human skin with its color. To understand melanoma, one must first understand the melanocyte. These specialized cells are located in the basal layer of the epidermis, the outermost layer of the skin. Their primary function is the production of melanin, a pigment that serves as a natural defense mechanism against the harmful effects of ultraviolet radiation.

When skin is exposed to the sun, melanocytes increase their production of melanin to protect the DNA within skin cells, a process commonly recognized as tanning. However, when the genetic material within these melanocytes becomes damaged—usually through cumulative or intense bursts of UV exposure—the cells can begin to grow uncontrollably, forming a malignant tumor known as melanoma.

While melanoma is less common than other forms of skin cancer, such as basal cell carcinoma or squamous cell carcinoma, it is significantly more dangerous because of its propensity to spread, or metastasize, to other parts of the body. If the cancer cells penetrate deep enough into the skin to reach the lymphatic system or the bloodstream, they can travel to distant organs like the lungs, liver, or brain. This aggressive nature is why early detection and an understanding of the biological mechanisms of the disease are so critical for survival.

Understanding Melanoma Skin Cancer
The development of melanoma is a multi-step process driven by genetic mutations. In recent decades, researchers have identified specific driver mutations causing melanocytes to bypass the body’s natural cell-cycle checkpoints. The most famous of these is the BRAF mutation, which is found in approximately half of all melanoma cases. Under normal conditions, the BRAF protein acts as a switch that tells cells when to grow. In melanoma, this switch is permanently stuck in the on position, leading to rapid and disorganized cellular proliferation. Other common mutations involve genes like NRAS and KIT, which also play roles in the signaling pathways that govern cell survival and growth.

Melanoma often begins as a new mole or a change in an existing one. Because melanocytes produce pigment, these tumors are typically brown or black, though they can occasionally appear pink, red, or even white in a variant known as amelanotic melanoma. Clinicians often teach the public to look for specific physical characteristics, focusing on asymmetry, irregular borders, varied coloring, a diameter larger than a pencil eraser, and evolution. Evolution refers to any change in size, shape, or symptoms like itching or bleeding. A mole that looks significantly different from all other moles on a person’s body, often called the ugly duckling sign, is a frequent indicator of malignancy.

Genetic Mutations That Drive Melanoma Growth
Risk factors for melanoma come from environmental exposure and inherited genetics. Ultraviolet radiation from the sun or tanning beds is the most significant preventable risk factor. It is important to note that the pattern of exposure matters; while chronic, long-term exposure is linked to other skin cancers, melanoma is frequently associated with intense, blistering sunburns, particularly those experienced during childhood or adolescence. However, genetics also plays a massive role. People with fair skin, light hair, and blue or green eyes have less natural melanin to protect their DNA and are thus at higher risk. Additionally, a family history of the disease or the presence of many atypical moles can increase a person’s baseline risk significantly.

Beyond the skin, melanoma can occur in places the sun rarely reaches. This is because melanocytes exist in other parts of the body. Uveal melanoma, for instance, develops in the iris or the choroid of the eye. Mucosal melanoma can appear in the respiratory tract, the gastrointestinal tract, or other mucous membranes. There is also acral lentiginous melanoma, which appears on the palms of the hands, soles of the feet, or under the fingernails. This specific type is not clearly linked to UV exposure and is the most common form of melanoma found in individuals with darker skin tones, highlighting that anyone, regardless of their complexion, can be affected by this disease.

How Melanoma Is Diagnosed and Staged
Once a suspicious lesion is identified, the diagnostic process begins with a biopsy. A dermatopathologist examines the tissue under a microscope to determine the Breslow thickness, which is a measurement of how deep the tumor has invaded the skin. This measurement is the single most important factor in determining the patient’s prognosis. A thin melanoma that is caught while still confined to the epidermis has a nearly one hundred percent cure rate through surgical excision. However, as thickness increases, so does the risk that the cancer has reached the body’s lymphatic system.

If the melanoma has progressed beyond the initial site, the staging process involves checking the sentinel lymph nodes, which are the first nodes to which a tumor is likely to spread. If these nodes are clear, the cancer is likely localized. If they contain cancer cells, the stage is increased, and the treatment plan becomes more systemic. In the past, metastatic melanoma had a very poor prognosis, with few patients surviving more than a year. However, the last decade has seen a significant shift in outcomes due to the advent of immunotherapy.

Immunotherapy works by unmasking the cancer cells so that the patient’s own immune system can recognize and destroy them. Melanoma is a highly immunogenic tumor, meaning it has many mutations that the immune system should theoretically be able to spot. However, cancer cells often use checkpoints to trick the immune system into leaving them alone. Drugs known as checkpoint inhibitors block these signals, allowing T-cells to attack the tumor.

Preventing Melanoma and Protecting Your Skin
Prevention remains the most effective tool in the fight against melanoma. This involves a multi-pronged approach of physical protection and regular surveillance. Broad-spectrum sunscreens that protect against both UVA and UVB rays are essential, but they are not a total shield. Protective clothing, seeking shade during peak hours of solar intensity, and avoiding artificial tanning remain the gold standards of prevention. Furthermore, regular skin self-examinations and annual checks by a board-certified dermatologist can ensure that any malignant changes are caught at their most treatable stage.

The psychological impact of a melanoma diagnosis should not be underestimated. Because it is a cancer that is often visible on the surface of the body, patients may deal with anxiety regarding their appearance and a heightened fear of the sun, which was once a source of vitamin D and joy. Support groups and education are vital components of the healing process, helping survivors navigate a new normal where skin health becomes a top priority.

As research continues, the goal is to reach a point where no one dies from melanoma. Scientists are currently working on personalized cancer vaccines that are custom-made for an individual’s specific tumor mutations. They are also investigating why some patients become resistant to immunotherapy and how to combine different treatments to achieve better results. The study of the microenvironment, the area immediately surrounding the tumor, also yields clues about how the body inadvertently helps cancer grow and how that help can be cut off.

Melanoma is a complex, aggressive malignancy of the pigment-producing cells. It is a disease defined by genetic damage, often caused by the very sun that sustains life on earth. While it remains a dangerous foe, the combination of public awareness, early surgical intervention, and the revolutionary progress in targeted and immunotherapy has changed the narrative of the disease. What was once a death sentence is now, for many, a hurdle that can be cleared with the help of modern medicine.

Comprehensive Cancer Centers Can Help
Physicians at Comprehensive Cancer Centers provide a variety of treatment options for patients with melanoma with all treatments being done in Southern Nevada. To schedule an appointment, please call 702-952-3350.

The content in this post is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of qualified health providers with questions you may have regarding medical conditions.

Close Menu